Skip to main content
. 2022 Mar 16;60(3):e02245-21. doi: 10.1128/jcm.02245-21

FIG 1.

FIG 1

Timeline of events during the hospital admission and ceftazidime-avibactam treatment received by patients A, B, and C. Yellow bars represent duration of treatment with ceftazidime-avibactam. Samples with the framed dates are those that were subsequently tested for the screening of KPC-carbapenemase and analyzed by whole-genome sequencing. CAZ/AVI, ceftazidime-avibactam; CP, carbapenemase; ESBL, extended-spectrum β-lactamase.